These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12521379)

  • 1. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3.
    Dumoutier L; Lejeune D; Hor S; Fickenscher H; Renauld JC
    Biochem J; 2003 Mar; 370(Pt 2):391-6. PubMed ID: 12521379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
    J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
    Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC
    J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
    Bellido T; Borba VZ; Roberson P; Manolagas SC
    Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
    Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers.
    Bahrenberg G; Behrmann I; Barthel A; Hekerman P; Heinrich PC; Joost HG; Becker W
    Mol Endocrinol; 2002 Apr; 16(4):859-72. PubMed ID: 11923481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK/STAT-dependent gene regulation by cytokines.
    Hebenstreit D; Horejs-Hoeck J; Duschl A
    Drug News Perspect; 2005 May; 18(4):243-9. PubMed ID: 16034480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
    Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M
    Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
    Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
    J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes.
    Kotenko SV; Pestka S
    Oncogene; 2000 May; 19(21):2557-65. PubMed ID: 10851054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.